Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Nishanta Singh

Datos Biográficos

ID7727307
NOMBRENishanta Singh
NOMBRESNishanta
APELLIDOSingh
FIRMASINGH N
AFILIACIONESSouth African Medical Research Council
VERIFICADONo
TOTAL DE OBRAS5
TOTAL DE CITAS0
TOTAL COMO AUTOR5
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2019
AÑO MÁS RECIENTE DE PUBLICACIÓN2024
ÍNDICE H0
  • Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa

    Open Access•Nigel Garrett, Tarylee Reddy et al.•ARTICLE•PLOS Global Public Health•2024

    Limited studies have been conducted on the safety and effectiveness of heterologous COVID-19 vaccine boosting in lower income settings, especially those with high-HIV prevalence., The Sisonke Heterologous mRNA-1273 boost after prime with Ad26.COV2.S (SHERPA) trial evaluated a mRNA-1273 boost after Ad26.COV2.S priming in South Africa. SHERPA was a single-arm, open-label, phase 3 study nested in the Sisonke implementation trial of 500000 healthcare…

  • Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South Africa

    Open Access•Mookho Malahleha, Fatima Laher et al.•ARTICLE•AIDS and Behavior•2023

    In South Africa, HIV acquisition risk has been studied less in people assigned male at birth. We studied the associations between risk behaviors, clinical features and HIV incidence amongst males in two South African HIV preventive vaccine efficacy trials. We used Cox proportional hazards models to test for associations between demographics, sexual behaviors, clinical variables and HIV acquisition among males followed in the HVTN 503 (n = 219) an…

  • Impact and experience of participant engagement activities in supporting dapivirine ring use among participants enrolled in the phase III MTN-020/Aspire study

    Open Access•Morgan Garcia, Ellen Luecke et al.•ARTICLE•BMC Public Health•2021

    Our analysis supports the growing body of work illustrating the importance of meaningfully engaging research participants to achieve study success and aligns with other analyses of adherence support efforts during ASPIRE. While causation between PEA attendance and product use cannot be established, residual drug levels in returned rings strongly correlated with participant attendance at PEAs, and the benefits of incorporating PEAs should be consi…

  • The Influence of Perceived Dapivirine Vaginal Ring Effectiveness on Social Disclosure and Ring Adherence

    Open Access•Marie C D Stoner, Elizabeth R Brown et al.•ARTICLE•AIDS and Behavior•2021

  • Impact of Male Partner Involvement on Women’s Adherence to the Dapivirine Vaginal Ring During a Phase III HIV Prevention Trial

    Open Access•for the MTN-020/ASPIRE Team, Sarah T Roberts et al.•ARTICLE•AIDS and Behavior•2019

Sin obras prominentes en esta página.

  • Impact of Male Partner Involvement on Women’s Adherence to the Dapivirine Vaginal Ring During a Phase III HIV Prevention Trial

    Open Access•for the MTN-020/ASPIRE Team, Sarah T Roberts et al.•ARTICLE•AIDS and Behavior•2019

  • Impact and experience of participant engagement activities in supporting dapivirine ring use among participants enrolled in the phase III MTN-020/Aspire study

    Open Access•Morgan Garcia, Ellen Luecke et al.•ARTICLE•BMC Public Health•2021

    Our analysis supports the growing body of work illustrating the importance of meaningfully engaging research participants to achieve study success and aligns with other analyses of adherence support efforts during ASPIRE. While causation between PEA attendance and product use cannot be established, residual drug levels in returned rings strongly correlated with participant attendance at PEAs, and the benefits of incorporating PEAs should be consi…

  • The Influence of Perceived Dapivirine Vaginal Ring Effectiveness on Social Disclosure and Ring Adherence

    Open Access•Marie C D Stoner, Elizabeth R Brown et al.•ARTICLE•AIDS and Behavior•2021

  • Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South Africa

    Open Access•Mookho Malahleha, Fatima Laher et al.•ARTICLE•AIDS and Behavior•2023

    In South Africa, HIV acquisition risk has been studied less in people assigned male at birth. We studied the associations between risk behaviors, clinical features and HIV incidence amongst males in two South African HIV preventive vaccine efficacy trials. We used Cox proportional hazards models to test for associations between demographics, sexual behaviors, clinical variables and HIV acquisition among males followed in the HVTN 503 (n = 219) an…

  • Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa

    Open Access•Nigel Garrett, Tarylee Reddy et al.•ARTICLE•PLOS Global Public Health•2024

    Limited studies have been conducted on the safety and effectiveness of heterologous COVID-19 vaccine boosting in lower income settings, especially those with high-HIV prevalence., The Sisonke Heterologous mRNA-1273 boost after prime with Ad26.COV2.S (SHERPA) trial evaluated a mRNA-1273 boost after Ad26.COV2.S priming in South Africa. SHERPA was a single-arm, open-label, phase 3 study nested in the Sisonke implementation trial of 500000 healthcare…

Medicine (5 obras) · HIV, Drug Use, Sexual Risk (4 obras) · HIV/AIDS Research and Interventions (4 obras) · Public health (4 obras) · Environmental health (3 obras) · Health psychology (3 obras) · Internal Medicine (3 obras) · Nursing (3 obras) · Population (3 obras) · Adolescent Sexual and Reproductive Health (2 obras)

Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae